Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Last updated: April 28, 2025
Sponsor: Washington University School of Medicine
Overall Status: Active - Recruiting

Phase

N/A

Condition

Cancer (Pediatric)

Retinoblastoma

Neuroblastoma

Treatment

Highlighting Patients at Risk for Sensory Screening (HPARSS)

Clinical Study ID

NCT05582551
202208066
  • Ages 7-17
  • All Genders

Study Summary

The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS). Using a cross sectional design study, collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the highlighting patients at risk for sensory screening (HPARSS) document. The investigators will utilize the HPARSS that will link therapy related risks for sensory deficits to specific screening procedures prompting the primary oncology provider to implement screening, diagnostic testing, and therapy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with a diagnosis of pediatric cancer (diagnosis at <18 years of age)

  • Treatment including chemotherapy and/or radiation therapy

  • Completion of all cancer therapy for at least 6 months and less than 2 years

  • Followed in the Division of Pediatric Hematology/Oncology Program at the WashingtonUniversity School of Medicine

  • Current age between 7 and 17 years of age (age where all of the screening tests areboth valid and have been successfully performed by our group)

  • English speaking

Exclusion

Exclusion Criteria:

  • Undergoing active cancer treatment

  • Patient under the care of the Late Effects Program at St. Louis Children's Hospital

  • Received previous diagnostic testing or rehabilitative therapy for a secondarydeficit eligible for screening.

  • Parents and/or patient illiteracy

  • No contact with treatment team in the past two years

  • In foster care or without a legal guardian

Study Design

Total Participants: 146
Treatment Group(s): 1
Primary Treatment: Highlighting Patients at Risk for Sensory Screening (HPARSS)
Phase:
Study Start date:
August 02, 2023
Estimated Completion Date:
May 31, 2026

Connect with a study center

  • St. Louis Children's Hospital - Washington University School of Medicine

    Saint Louis, Missouri 63110
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.